Related Experiment Video
Updated: Jan 3, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Pediatric Ventricular Assist Device
Yu Rim Shin1, Young Hwan Park1, Han Ki Park2
1Division of Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
Insights
Ventricular assist devices (VADs) offer improved outcomes for pediatric heart failure patients awaiting transplants. Careful patient selection and device choice are crucial for successful VAD therapy and better post-transplant results.
Area of Science:
- Pediatric cardiology
- Cardiovascular surgery
- Biomedical engineering
Background:
- Advanced heart failure in children necessitates advanced treatment options.
- Ventricular assist devices (VADs) are increasingly utilized for pediatric patients.
- VADs can bridge patients to heart transplantation, improving their condition.
Purpose of the Study:
- To review the advancements and outcomes of VAD therapy in pediatric patients.
- To highlight the benefits of VAD support on heart failure symptoms and post-transplant results.
- To identify critical factors influencing outcomes in pediatric VAD recipients.
Main Methods:
- Review of current literature on pediatric VAD implantation and outcomes.
- Analysis of the impact of continuous flow and paracorporeal pulsatile devices.
- Identification of risk factors associated with VAD support in young patients.
Main Results:
- Miniaturized continuous flow VADs show promising results in pediatric patients.
- Paracorporeal pulsatile devices remain the option for infants and small children.
- Factors like younger age, congenital heart disease, and end-organ dysfunction are linked to poorer outcomes.
Conclusions:
- VAD therapy significantly improves the condition of pediatric heart failure patients.
- Optimal patient selection, precise timing of implantation, and appropriate device choice are paramount.
- VAD support positively influences post-transplant outcomes in pediatric recipients.
Abstract:
There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list. Augmented cardiac output improves heart failure symptoms, end-organ function, and general condition, and consequently provides beneficial effects on post-transplant outcomes. Miniaturized continuous flow devices are more widely adopted for pediatric patient with promising results. For infants and small children, still paracorporeal pulsatile device is the only option for long-term support. Younger age, congenital heart disease, biventricular support, patient's status and end-organ dysfunction at the time of implantation are risks for poor outcomes. Patient selection, timing of implantation, and selection of device for each patient are critical for optimal clinical outcomes.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation I: Indication and Settings